Reticcount 349204Recalls & reported problems
Becton, Dickinson And Company · Retic-Count Reticulocyte Rgnt System IVD · Class 2
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00382903492046), received between Jul 20, 2021 and Jul 20, 2021 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Illegible Information” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Illegible Information2
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 20, 2021Illegible Information; Illegible Information
IT WAS REPORTED THAT THE PACKAGING WAS LEAKING AND PRODUCTS LABEL INFORMATION WAS ERASED WITH BD RETIC-COUNT¿. THERE WAS NO USER IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM FRENCH TO ENGLISH: (1 OF 2 COMPLAINTS) ON THE OTHER HAND, UPON RECEIPT, WE NOTICED THAT THE PRODUCT WAS LEAKING DESPITE THE PACKAGING PRECAUTIONS. THE PREVIOUS BATCH WAS ALSO LEAKING. MOREOVER, EACH TIME, THE LABEL IS COMPLETELY ERASED. THIS PRODUCT IS LIKELY TO BE CARCINOGENIC (SEE DATA SHEET), AND WITH THIS PROBLEM OF LEAKAGE, WE PUT SOME EVERYWHERE ON THE GLOVES, THE MAT... COULD YOU PLEASE FORWARD OUR REMARKS TO THE COMPETENT SERVICE IN ORDER TO GUARANTEE A BETTER SAFETY OF THE USERS. - WE DID NOT COME INTO CONTACT WITH THE PRODUCT WITHOUT PROTECTIVE EQUIPMENT, WE ALWAYS HANDLED IT WITH GLOVES. HOWEVER, THE BENCH WAS CONTAMINATED AND WE DECONTAMINATED IT WITH ACTIVATED CARBON. CAN YOU CONFIRM THAT THIS PRODUCT IS INDEED CARCINOGENIC?
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12197522 ↗MalfunctionJul 20, 2021Illegible Information; Illegible Information
IT WAS REPORTED THAT THE PACKAGING WAS LEAKING AND PRODUCTS LABEL INFORMATION WAS ERASED WITH BD RETIC-COUNT¿. THERE WAS NO USER IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM (B)(6) TO ENGLISH: (2 OF 2 COMPLAINTS): ON THE OTHER HAND, UPON RECEIPT, WE NOTICED THAT THE PRODUCT WAS LEAKING DESPITE THE PACKAGING PRECAUTIONS. THE PREVIOUS BATCH WAS ALSO LEAKING. MOREOVER, EACH TIME, THE LABEL IS COMPLETELY ERASED. THIS PRODUCT IS LIKELY TO BE CARCINOGENIC, AND WITH THIS PROBLEM OF LEAKAGE, WE PUT SOME EVERYWHERE ON THE GLOVES THE MAT. COULD YOU PLEASE FORWARD OUR REMARKS TO THE COMPETENT SERVICE IN ORDER TO GUARANTEE A BETTER SAFETY OF THE USERS. WE DID NOT COME INTO CONTACT WITH THE PRODUCT WITHOUT PROTECTIVE EQUIPMENT, WE ALWAYS HANDLED IT WITH GLOVES. HOWEVER, THE BENCH WAS CONTAMINATED AND WE DECONTAMINATED IT WITH ACTIVATED CARBON. CAN YOU CONFIRM THAT THIS PRODUCT IS INDEED CARCINOGENIC?
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12197520 ↗
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.